BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, Michielin O, Peters S, Tabernero J, Douillard JY, Pentheroudakis G; Panel members. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol 2020;31:1320-35. [PMID: 32745693 DOI: 10.1016/j.annonc.2020.07.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 36.5] [Reference Citation Analysis]
Number Citing Articles
1 Spano JP, Barre-Sinoussi F, Kieny MP, Marcelin AG, Blay JY. [COVID-19 vaccination for cancer patients: Medical and ethical need]. Bull Cancer 2021;108:225-7. [PMID: 33674059 DOI: 10.1016/j.bulcan.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Brugel M, Letrillart L, Evrard C, Thierry A, Tougeron D, El Amrani M, Piessen G, Truant S, Turpin A, Christelle d'Engremont, Roth G, Hautefeuille V, Regimbeau JM, Williet N, Schwarz L, Di Fiore F, Borg C, Doussot A, Lambert A, Moulin V, Trelohan H, Bolliet M, Topolscki A, Ayav A, Lopez A, Botsen D, Piardi T, Carlier C, Bouché O. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort study (CAPANCOVID). European Journal of Cancer 2022. [DOI: 10.1016/j.ejca.2022.01.040] [Reference Citation Analysis]
3 Bernabe-Ramirez C, Velazquez AI, Olazagasti C, Decat Bergerot C, Bergerot PG, Corona Cruz J, Riano I, Adaniel C, Ramirez F, Anampa J, Cajina C, Mena E, Gracia E, Menendez A, Idrovo H, Bezares R, Castillo Fernandez OO, Duque L, Corrales-Rodríguez L, Ramos G, Kihn-Alarcón AJ, Schlam I, Bruno X, Umanzor G, Castro JL, Losco F, Ubillos L, Richardet E, Soto-Perez-de-Celis E, Duma N; HOLA COVID-19 Study Group. HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America. JCO Glob Oncol 2022;8:e2100251. [PMID: 35245084 DOI: 10.1200/GO.21.00251] [Reference Citation Analysis]
4 Kempf E, Priou S, Lamé G, Daniel C, Bellamine A, Sommacale D, Belkacemi Y, Bey R, Galula G, Taright N, Tannier X, Rance B, Flicoteaux R, Hemery F, Audureau E, Chatellier G, Tournigand C; on behalf of the Assistance Publique-Hôpitaux de Paris Cancer Group. Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals. Int J Cancer 2022. [PMID: 35001364 DOI: 10.1002/ijc.33928] [Reference Citation Analysis]
5 Freer PE. The Impact of the COVID-19 Pandemic on Breast Imaging. Radiol Clin North Am 2021;59:1-11. [PMID: 33222992 DOI: 10.1016/j.rcl.2020.09.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
6 Lasagna A, Muzzana M, Pedrazzoli P. Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research. Immunotherapy 2021;13:1369-72. [PMID: 34585970 DOI: 10.2217/imt-2021-0219] [Reference Citation Analysis]
7 Eijkelboom AH, de Munck L, Vrancken Peeters MTFD, Broeders MJM, Strobbe LJA, Bos MEMM, Schmidt MK, Guerrero Paez C, Smidt ML, Bessems M, Verloop J, Linn S, Lobbes MBI, Honkoop AH, van den Bongard DHJG, Westenend PJ, Wesseling J, Menke-van der Houven van Oordt CW, Tjan-Heijnen VCG, Siesling S; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol 2021;14:64. [PMID: 33865430 DOI: 10.1186/s13045-021-01073-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cantini L, Mentrasti G, Lo Russo G, Signorelli D, Pasello G, Rijavec E, Russano M, Antonuzzo L, Rocco D, Giusti R, Adamo V, Genova C, Tuzi A, Morabito A, Gori S, La Verde N, Chiari R, Cortellini A, Cognigni V, Pecci F, Indini A, De Toma A, Zattarin E, Oresti S, Pizzutilo EG, Frega S, Erbetta E, Galletti A, Citarella F, Fancelli S, Caliman E, Della Gravara L, Malapelle U, Filetti M, Piras M, Toscano G, Zullo L, De Tursi M, Di Marino P, D'emilio V, Cona MS, Guida A, Caglio A, Salerno F, Spinelli G, Bennati C, Morgillo F, Russo A, Dellepiane C, Vallini I, Sforza V, Inno A, Rastelli F, Tassi V, Nicolardi L, Pensieri V, Emili R, Roca E, Migliore A, Galassi T, Bruno Rocchi ML, Berardi R. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100406] [Reference Citation Analysis]
9 Barcellini A, Massaro M, Dal Mas F, Langendijk JA, Høyer M, Calugaru V, Haustermans K, Timmermann B, Thariat J, Scartoni D, Vennarini S, Georg P, Orlandi E. A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group. Clinical and Translational Radiation Oncology 2022;34:1-6. [DOI: 10.1016/j.ctro.2022.02.004] [Reference Citation Analysis]
10 Messika J, Roux A, Dauriat G, Pavec JL. Lung Transplantation in the COVID-19 Era: A Multi-Faceted Challenge. Respiratory Medicine and Research 2021. [DOI: 10.1016/j.resmer.2021.100866] [Reference Citation Analysis]
11 Yasin AI, Topcu A, Shbair AT, Isleyen ZS, Ozturk A, Besiroglu M, Türk HM. Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic. Future Oncol 2021;17:3373-81. [PMID: 34291649 DOI: 10.2217/fon-2020-1265] [Reference Citation Analysis]
12 Hennessy MA, Linehan A, Cowzer D, Coyne ZL, Fitzpatrick O, Barrett F, Ni Dhonaill R, Hennessy BT, Grogan L, Morris PG, Breathnach OS. Chemotherapy in the Covid-19 era: the patient's perception. Ir J Med Sci 2021. [PMID: 33449325 DOI: 10.1007/s11845-020-02457-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kaiser U, Vehling-Kaiser U, Schmidt J, Hoffmann A, Kaiser F. The tumor patient in the COVID-19 pandemic-an interview-based study of 30 patients undergoing systemic antiproliferative therapy. PLoS One 2021;16:e0256047. [PMID: 34379682 DOI: 10.1371/journal.pone.0256047] [Reference Citation Analysis]
14 Berger JM, Gansterer M, Trutschnig W, Bathke AC, Strassl R, Lamm W, Raderer M, Preusser M, Berghoff AS. SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center. Wien Klin Wochenschr 2021;133:909-14. [PMID: 34410467 DOI: 10.1007/s00508-021-01927-7] [Reference Citation Analysis]
15 Wasim U, Tahir MJ, Siddiqi AR, Jabbar A, Ullah I. The impact of the COVID-19 pandemic on impending cancer deaths due to delays in diagnosis in the UK. J Med Virol 2022;94:20-1. [PMID: 34453760 DOI: 10.1002/jmv.27305] [Reference Citation Analysis]
16 Berger JM, Wohlfarth P, Königsbrügge O, Knaus HA, Porpaczy E, Kaufmann H, Schreiber J, Mrva-Ghukasyan T, Winder T, Severgnini L, Wolf D, Petzer V, Nguyen VA, Weinlich G, Öhler L, Wonnerth A, Miksovsky A, Engelhart B, Preusser M, Berghoff AS. SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study. Wien Klin Wochenschr 2022. [PMID: 35171337 DOI: 10.1007/s00508-022-02006-1] [Reference Citation Analysis]
17 Onesti CE, Tagliamento M, Curigliano G, Harbeck N, Bartsch R, Wildiers H, Tjan-Heijnen V, Martin M, Rottey S, Generali D, Campone M, Cristofanilli M, Pusztai L, Peeters M, Berchem G, Cortes J, Ruhstaller T, Ciruelos E, Rugo HS, Jerusalem G. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology. JCO Glob Oncol 2021;7:162-72. [PMID: 33529077 DOI: 10.1200/GO.20.00589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
18 Arrieta O, Lara-Mejía L, Bautista-González E, Heredia D, Turcott JG, Barrón F, Ramos-Ramírez M, Cabrera-Miranda L, Salinas Padilla MÁ, Aguerrebere M, Cardona AF, Rolfo C, Arroyo-Hernández M, Soto-Pérez-de-Celis E, Baéz-Saldaña R. Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies. Oncologist 2021. [PMID: 34498780 DOI: 10.1002/onco.13962] [Reference Citation Analysis]
19 Federico A, Fragomeni SM, Tagliaferri L, Guajardo Rios LS, Lancellotta V, Gentileschi S, Corrado G, Gui B, Colloca G, Rufini V, Fagotti A, Scambia G, Garganese G. Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team. Int J Gynecol Cancer 2021:ijgc-2021-003026. [PMID: 34903559 DOI: 10.1136/ijgc-2021-003026] [Reference Citation Analysis]
20 Tse T, Sehdev S, Seely J, Gravel DH, Clemons M, Cordeiro E, Arnaout A. Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic. Curr Oncol 2021;28:1338-47. [PMID: 33805031 DOI: 10.3390/curroncol28020127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Akingboye A, Mahmood F, Amiruddin N, Reay M, Nightingale P, Ogunwobi OO. Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study. BMJ Open 2021;11:e053352. [PMID: 34903546 DOI: 10.1136/bmjopen-2021-053352] [Reference Citation Analysis]
22 Yekedüz E, Utkan G, Ürün Y. Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? J Oncol Pharm Pract 2021;27:450-2. [PMID: 33470163 DOI: 10.1177/1078155220988753] [Reference Citation Analysis]
23 Jazieh AR, Bensalem AA, Bounedjar A, Benbrahim Z, Alorabi MO, Abusanad AM, Tashkandi EM, Alnassar MA, El Kinge AR, Al-Sukhun S, Alsharm A, Errihani H, Abdelhafiez NA, Alkaiyat M, Jradi H. Predictors of poor precautionary practices towards COVID-19 among cancer patients. Future Oncol 2021. [PMID: 34472365 DOI: 10.2217/fon-2021-0193] [Reference Citation Analysis]
24 Jazieh AR, Alghamdi M, Alkaiyat M, Al Johani SM, Damlaj M. A retrospective evaluation of the value of COVID-19 screening and testing in patients with cancer: Aiming at a moving target. J Infect Public Health 2021;14:949-53. [PMID: 34130118 DOI: 10.1016/j.jiph.2021.05.005] [Reference Citation Analysis]
25 Tomo S, Kumar KP, Roy D, Sankanagoudar S, Purohit P, Yadav D, Banerjee M, Sharma P, Misra S. Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol 2021;14:155-73. [PMID: 33480807 DOI: 10.1080/17474086.2021.1875813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Marijanović I, Kraljević M, Buhovac T, Cerić T, Mekić Abazović A, Alidžanović J, Gojković Z, Sokolović E. Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic. Med Sci Monit 2021;27:e930812. [PMID: 33867520 DOI: 10.12659/MSM.930812] [Reference Citation Analysis]
27 Zon RT, Kennedy EB, Adelson K, Blau S, Dickson N, Gill D, Laferriere N, Lopez AM, Mulvey TM, Patt D, Pickard TA, Purdom T, Royce TJ, Sumrall AL, Page RD. Telehealth in Oncology: ASCO Standards and Practice Recommendations. JCO Oncol Pract 2021;17:546-64. [PMID: 34319760 DOI: 10.1200/OP.21.00438] [Reference Citation Analysis]
28 Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer 2021;9:e002266. [PMID: 33737345 DOI: 10.1136/jitc-2020-002266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin Z, Chen J, Han S. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis. Expert Rev Anticancer Ther 2021;21:1055-66. [PMID: 33970745 DOI: 10.1080/14737140.2021.1927721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Eufrasia Ledda R, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clin Med Insights Oncol 2021;15:11795549211043427. [PMID: 34526833 DOI: 10.1177/11795549211043427] [Reference Citation Analysis]
31 Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, I Jzerman M, Solomon B. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. ESMO Open 2020;5:e001090. [PMID: 33262203 DOI: 10.1136/esmoopen-2020-001090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Dilawari A, Rentscher KE, Zhai W, Zhou X, Ahles TA, Ahn J, Bethea TN, Carroll JE, Cohen HJ, Graham DA, Jim H, McDonald B, Nakamura ZM, Patel SK, Root JC, Small BJ, Saykin AJ, Tometich D, Van Dyk K, Mandelblatt JS; Thinking and Living with Cancer Study. Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors. Res Sq 2021:rs. [PMID: 33880464 DOI: 10.21203/rs.3.rs-416077/v1] [Reference Citation Analysis]
33 Chow MC, Chambers P, Singleton G, Patel J, Cooper S, Mythen C, Bautista-González E, Chisnall G, Djellouli N, Thwaites B, Wong IC, Vindrola-Padros C. Global changes to the chemotherapy service during the covid-19 pandemic. J Oncol Pharm Pract 2021;27:1073-9. [PMID: 33983080 DOI: 10.1177/10781552211015767] [Reference Citation Analysis]
34 Quero G, Pecorelli N, Paiella S, Fiorillo C, Petrone MC, Rosa F, Capretti G, Laterza V, Kauffmann E, Nobile S, Butturini G, Ferrari G, Coratti A, Casadei R, Mazzaferro V, Boggi U, Zerbi A, Salvia R, Falconi M, Alfieri S. Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers. Updates Surg 2021. [PMID: 34817837 DOI: 10.1007/s13304-021-01171-8] [Reference Citation Analysis]
35 Marino P, Touzani R, Pakradouni J, Ben Soussan P, Gravis G. The Psychological Distress of Cancer Patients following the COVID-19 Pandemic First Lockdown: Results from a Large French Survey. Cancers 2022;14:1794. [DOI: 10.3390/cancers14071794] [Reference Citation Analysis]
36 Castelo-branco L, Tsourti Z, Gennatas S, Rogado J, Sekacheva M, Viñal D, Lee R, Croitoru A, Vitorino M, Khallaf S, Šušnjar S, Soewoto W, Cardeña A, Djerouni M, Rossi M, Alonso-gordoa T, Ngelangel C, Whisenant JG, Choueiri TK, Dimopoulou G, Pradervand S, Arnold D, Harrington K, Michielin O, Dafni U, Pentheroudakis G, Peters S, Romano E. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO CoCARE). ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100499] [Reference Citation Analysis]
37 Joseph A, Olatosi B, Haider MR, Adegboyega BC, Lasebikan NN, Aliyu UM, Ali-Gombe M, Jimoh MA, Biyi-Olutunde OA, Awofeso O, Fatiregun OA, Oboh EO, Nwachukwu E, Zubairu IH, Otene SA, Iyare OI, Andero T, Musbau AB, Ajose A, Onitilo AA. Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria. JCO Glob Oncol 2022;8:e2100244. [PMID: 35157511 DOI: 10.1200/GO.21.00244] [Reference Citation Analysis]
38 Fontes-Sousa M, Magalhães H, Oliveira A, Carneiro F, Dos Reis FP, Madeira PS, Meireles S. Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy? Adv Ther 2022. [PMID: 35025061 DOI: 10.1007/s12325-021-02007-y] [Reference Citation Analysis]
39 Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Merli M, Tonella L, Ribero S, Fierro MT. Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit. Future Oncol 2021;17:759-61. [PMID: 33533662 DOI: 10.2217/fon-2020-0997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kamposioras K, Mauri D, Papadimitriou K, Anthoney A, Hindi N, Petricevic B, Dambrosio M, Valachis A, Kountourakis P, Kopecky J, Kuhar CG, Popovic L, Chilingirova NP, Zarkavelis G, de Mello RA, Plavetić ND, Christopoulos C, Mostert B, Goffin JR, Tzachanis D, Saraireh HH, Ma F, Pavese I, Tolia M. Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth. Front Oncol 2020;10:575148. [PMID: 33330049 DOI: 10.3389/fonc.2020.575148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Martei YM, Rick TJ, Fadelu T, Ezzi MS, Hammad N, Quadri NS, Rodrigues B, Simonds H, Grover S, Incrocci L, Vanderpuye V. Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in Africa. JCO Glob Oncol 2021;7:368-77. [PMID: 33689484 DOI: 10.1200/GO.20.00569] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Hulikal N, Kumar SN, Gopinath KS. Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context. Indian J Surg Oncol 2021;:1-5. [PMID: 34345154 DOI: 10.1007/s13193-021-01392-8] [Reference Citation Analysis]
43 Ferrari A, Trevenzoli M, Sasset L, Di Liso E, Tavian T, Rossi L, Di Meco E, Cattelan AM. Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment? Curr Oncol 2021;28:847-52. [PMID: 33567626 DOI: 10.3390/curroncol28010083] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Cortinovis D, Bidoli P, Canova S, Colonese F, Gemelli M, Lavitrano ML, Banna GL, Liu SV, Morabito A. Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma. Cancers (Basel) 2021;13:1152. [PMID: 33800236 DOI: 10.3390/cancers13051152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kassianos AP, Georgiou A, Kyprianidou M, Lamnisos D, Ļubenko J, Presti G, Squatrito V, Constantinou M, Nicolaou C, Papacostas S, Aydin G, Chong YY, Chien WT, Cheng HY, Ruiz FJ, Garcia-Martin MB, Obando D, Segura-Vargas MA, Vasiliou VS, McHugh L, Höfer S, Baban A, Neto DD, Silva AND, Monestès JL, Alvarez-Galvez J, Blarrina MP, Montesinos F, Salas SV, Őri D, Kleszcz B, Lappalainen R, Ivanović I, Gosar D, Dionne F, Merwin RM, Chatzittofis A, Konstantinou E, Economidou S, Gloster AT, Karekla M, Constantinidou A. Mental Health and Adherence to COVID-19 Protective Behaviors among Cancer Patients during the COVID-19 Pandemic: An International, Multinational Cross-Sectional Study. Cancers (Basel) 2021;13:6294. [PMID: 34944913 DOI: 10.3390/cancers13246294] [Reference Citation Analysis]
46 Watanabe H, Karayama M, Yasui H, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide. Cancer Treat Res Commun 2021;29:100493. [PMID: 34844181 DOI: 10.1016/j.ctarc.2021.100493] [Reference Citation Analysis]
47 Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-fenge H, Otto-knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer J, Worth H, Windisch W, Welte T, Bauer T. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians. Respiration 2022;101:307-20. [DOI: 10.1159/000518896] [Reference Citation Analysis]
48 Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, Türeci Ö, Şahin U, Xu X, Koury K, Dychter SS, Lu C, Gentile TC, Gruber WC. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine 2021:S0264-410X(21)01652-2. [PMID: 35131133 DOI: 10.1016/j.vaccine.2021.12.046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Basse C, Daniel C, Livartowski A, Beaucaire-Danel S, Girard N. Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center. Lung Cancer 2021;157:79-84. [PMID: 33994016 DOI: 10.1016/j.lungcan.2021.05.007] [Reference Citation Analysis]
50 Minichsdorfer C, Jeryczynski G, Krall C, Achhorner AM, Caraan A, Pasalic S, Reininger K, Wagner C, Bartsch R, Preusser M, Laggner A, Raderer M, Fuereder T. Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centre. Eur J Clin Invest 2021;51:e13623. [PMID: 34085717 DOI: 10.1111/eci.13623] [Reference Citation Analysis]
51 Castelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, Banerjee S, Giuliani R, Lordick F, Cervantes A, Tabernero J, Peters S. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. ESMO Open 2021;6:100237. [PMID: 34411971 DOI: 10.1016/j.esmoop.2021.100237] [Reference Citation Analysis]
52 El-Shakankery KH, Kefas J, Miller R. COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy. Front Oncol 2020;10:631611. [PMID: 33598436 DOI: 10.3389/fonc.2020.631611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Rogado J, Obispo B, Gullón P, Lara MÁ. Impact of the COVID-19 pandemic in cancer diagnosis in the first and second waves in one of the most affected cancer areas in the city of Madrid (Spain). Int J Cancer 2021;148:1794-5. [PMID: 33411962 DOI: 10.1002/ijc.33462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Gelderblom H, Veelken H, Stiggelbout AM. COVID-19 and systemic anticancer therapy: exploiting uncertainty. Lancet Oncol 2021;22:3-5. [PMID: 33253642 DOI: 10.1016/S1470-2045(20)30700-2] [Reference Citation Analysis]
55 Di Cosimo S, Tagliaferri B, Generali D, Giudici F, Agustoni F, Bernardo A, Borgonovo K, Farina G, Luchena G, Luciani A, Nolè F, Palmeri L, Pietrantonio F, Poggi G, Zucali PA, Balletti E, Catania G, Bernocchi O, D'Antonio F, Giordano M, Grossi F, Lasagna A, La Verde N, Manzoni M, Montagna B, Olgiati A, Raimondi A, Rampinelli I, Verri E, Zaniboni A, Di Maio M, Beretta G, Danova M. Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers (Basel) 2021;13:1324. [PMID: 33809465 DOI: 10.3390/cancers13061324] [Reference Citation Analysis]
56 Jain P, Balkrishanan K, Nayak S, Gupta N, Shah S. Onco-Anaesthesiology and palliative medicine: Opportunities and challenges. Indian J Anaesth 2021;65:29-34. [PMID: 33767500 DOI: 10.4103/ija.IJA_1556_20] [Reference Citation Analysis]
57 Cassetta L, Rodrigues P, Andreu T, Botta B, Brandau S, Brierley C, Wilson C, Dadeshidze I, Forzi L, Ortelli F, Quintas M. Beating Cancer by 2030: Mission Impossible? RIO 2020;6:e61662. [DOI: 10.3897/rio.6.e61662] [Reference Citation Analysis]
58 Koinig KA, Arnold C, Lehmann J, Giesinger J, Köck S, Willenbacher W, Weger R, Holzner B, Ganswindt U, Wolf D, Stauder R. The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic. Cancer Med 2021;10:3928-37. [PMID: 33973411 DOI: 10.1002/cam4.3950] [Reference Citation Analysis]
59 Cincidda C, Pizzoli SFM, Pravettoni G. Remote Psychological Interventions for Fear of Cancer Recurrence: Scoping Review. JMIR Cancer 2022;8:e29745. [PMID: 35014956 DOI: 10.2196/29745] [Reference Citation Analysis]
60 Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, IJzerman M, Solomon BJ. Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians. ESMO Open 2021;6:100224. [PMID: 34461484 DOI: 10.1016/j.esmoop.2021.100224] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Daguenet E, Magné N. [Use of telehealth services in the oncology setting: Daily routine and during sanitary crisis]. Bull Cancer 2021;108:627-34. [PMID: 33896585 DOI: 10.1016/j.bulcan.2021.01.017] [Reference Citation Analysis]
62 Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-Fenge H, Otto-Knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer FJ, Worth H, Windisch W, Welte T, Bauer T. [Risk Assessment for Patients with Chronic Respiratory and Pulmonary Conditions in the Context of the SARS-CoV-2 Pandemic - Statement of the German Respiratory Society (DGP) with the Support of the German Association of Respiratory Physicians (BdP)]. Pneumologie 2021;75:19-30. [PMID: 33242887 DOI: 10.1055/a-1321-3400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
63 Gounder DP, Trotman PJ. Favourable outcomes for young lymphoma patients but age-old problems persist. EClinicalMedicine 2020;28:100611. [PMID: 33169113 DOI: 10.1016/j.eclinm.2020.100611] [Reference Citation Analysis]
64 Kaya T, Dilek A, Ozaras R, Balcik OS, Leblebicioglu H. COVID 19 and febrile neutropenia: Case report and systematic review. Travel Med Infect Dis 2022;:102305. [PMID: 35272019 DOI: 10.1016/j.tmaid.2022.102305] [Reference Citation Analysis]
65 Toquero P, Blanco Fernández C, López Martí MP, Hernández Marín B, Vera Cea EB, Garrido García A, Méndez Carrascosa E, Bañón Torres D, Donnay Candil O, Ballesteros García AI, Sánchez-Torres JM, Costas Rojo P, Mondéjar R, Colomer R, Romero-Laorden N. Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic. Front Psychol 2021;12:755965. [PMID: 34803837 DOI: 10.3389/fpsyg.2021.755965] [Reference Citation Analysis]
66 Liontos M, Kastritis E, Markellos C, Migkou M, Eleftherakis-Papaiakovou E, Koutsoukos K, Gavriatopoulou M, Zagouri F, Psaltopoulou T, Terpos E, Dimopoulos MA. Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit. Cancers (Basel) 2021;13:763. [PMID: 33673120 DOI: 10.3390/cancers13040763] [Reference Citation Analysis]
67 Ehmsen S, Jakobsen LH, Lendorf ME, Eefsen RL, Bentsen L, Knoop AS, Aggerholm-Pedersen N, Skuladottir H, Herrstedt J, Jensen LH, Rotbøl C, Damm MB, Wedervang K, Glenthøj A, Ryg J, Frederiksen H, Kodahl AR. Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study. Acta Oncol 2021;60:859-65. [PMID: 33646071 DOI: 10.1080/0284186X.2021.1889659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Pinato DJ, Tabernero J, Bower M, Scotti L, Patel M, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar-Company J, Ottaviani D, Chowdhury A, Merry E, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita-Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Seguí E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Liñan R, Rossi S, Carmona-García MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Saponara M, Cruz CA, García-Illescas D, Felip E, Roqué Lloveras A, Sharkey R, Roldán E, Reyes R, Earnshaw I, Ferrante D, Marco-Hernández J, Ruiz-Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez-Vila C, Sanchez de Torre A, Cantini L, Filetti M, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Van Hemelrijck M, Diamantis N, Newsom-Davis T, Gennari A, Cortellini A; OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol 2021:S1470-2045(21)00573-8. [PMID: 34741822 DOI: 10.1016/S1470-2045(21)00573-8] [Reference Citation Analysis]
69 van Marcke C, Honoré N, van der Elst A, Beyaert S, Derouane F, Dumont C, Aboubakar Nana F, Baurain JF, Borbath I, Collard P, Cornélis F, De Cuyper A, Duhoux FP, Filleul B, Galot R, Gizzi M, Mazzeo F, Pieters T, Seront E, Sinapi I, Van den Eynde M, Whenham N, Yombi JC, Scohy A, van Maanen A, Machiels JP. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study. BMC Cancer 2021;21:578. [PMID: 34016086 DOI: 10.1186/s12885-021-08349-8] [Reference Citation Analysis]
70 Al-Mozaini M, Noman ASM, Alotaibi J, Karim MR, Zahed ASM, Karim ATMR, Alromiah K, Islam SS. SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer. Front Oncol 2021;11:715794. [PMID: 34490115 DOI: 10.3389/fonc.2021.715794] [Reference Citation Analysis]
71 Trojaniello C, Vitale MG, Ascierto PA. Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19. Ann Oncol 2021;32:674-6. [PMID: 33600920 DOI: 10.1016/j.annonc.2021.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Dabkeviciene D, Vincerzevskiene I, Urbonas V, Venius J, Dulskas A, Brasiuniene B, Janulionis E, Burneckis A, Zileviciene A, Tiskevicius S, Vanseviciute-Petkeviciene R, Usinskiene J, Briediene R, Bulotiene G, Stratilatovas E, Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S. The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience. Healthcare (Basel) 2021;9:1522. [PMID: 34828568 DOI: 10.3390/healthcare9111522] [Reference Citation Analysis]
73 Yap TA, Siu LL, Calvo E, Lolkema MP, LoRusso PM, Soria JC, Plummer R, de Bono JS, Tabernero J, Banerji U. SARS-CoV-2 vaccination and phase 1 cancer clinical trials. Lancet Oncol 2021;22:298-301. [PMID: 33571468 DOI: 10.1016/S1470-2045(21)00017-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
74 Duncan N, Deekes N, FitzGerald D, Ng TWT, Raghavan M. Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications. EJHaem 2021. [PMID: 34226902 DOI: 10.1002/jha2.220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Ashbury FD. COVID-19 and supportive cancer care: key issues and opportunities. Curr Opin Oncol 2021;33:295-300. [PMID: 33720066 DOI: 10.1097/CCO.0000000000000729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Chang CWD, McCoul ED, Briggs SE, Guardiani EA, Durand ML, Hadlock TA, Hillel AT, Kattar N, Openshaw PJM, Osazuwa-Peters N, Poetker DM, Shin JJ, Chandrasekhar SS, Bradford CR, Brenner MJ. Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era. Otolaryngol Head Neck Surg 2021;:1945998211064275. [PMID: 34874793 DOI: 10.1177/01945998211064275] [Reference Citation Analysis]
77 Ripamonti CI, Massa G, Insolvibile D, Guglielmo M, Miccinesi G, Regalia C, Saita E, Pagnini F. Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy. Tumori 2021;:3008916211022848. [PMID: 34176373 DOI: 10.1177/03008916211022848] [Reference Citation Analysis]
78 Chifu I, Detomas M, Dischinger U, Kimpel O, Megerle F, Hahner S, Fassnacht M, Altieri B. Management of Patients With Glucocorticoid-Related Diseases and COVID-19. Front Endocrinol (Lausanne) 2021;12:705214. [PMID: 34594302 DOI: 10.3389/fendo.2021.705214] [Reference Citation Analysis]
79 Rasschaert M, Vanclooster P, Depauw L, Mertens T, Roelant E, Coenen E, Anguille S, Janssens A, Van Dam P, Peeters M. Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis. Cancer Control 2021;28:10732748211045275. [PMID: 34623943 DOI: 10.1177/10732748211045275] [Reference Citation Analysis]
80 Zhang JT, Zhong WZ, Wu YL. Cancer treatment in the coronavirus disease pandemic. Lung Cancer 2021;152:98-103. [PMID: 33373838 DOI: 10.1016/j.lungcan.2020.12.012] [Reference Citation Analysis]
81 Bizot A, Karimi M, Rassy E, Heudel PE, Levy C, Vanlemmens L, Uzan C, Deluche E, Genet D, Saghatchian M, Giacchetti S, Grenier J, Patsouris A, Dieras V, Pierga JY, Petit T, Ladoire S, Jacot W, Benderra MA, De Jesus A, Delaloge S, Lambertini M, Pistilli B. Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic. Br J Cancer 2021;125:1486-93. [PMID: 34588616 DOI: 10.1038/s41416-021-01555-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Burgaletto C, Brunetti O, Munafò A, Bernardini R, Silvestris N, Cantarella G, Argentiero A. Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era. Cancers (Basel) 2021;13:1906. [PMID: 33921021 DOI: 10.3390/cancers13081906] [Reference Citation Analysis]
83 Kabalak PA, Kızılgöz D, Kavurgacı S, Yılmaz Ü. Clinical management of lung cancer patients with respiratory symptoms during the COVID-19 pandemic. Int J Clin Pract 2021;:e14993. [PMID: 34710277 DOI: 10.1111/ijcp.14993] [Reference Citation Analysis]
84 Pandy JG, Maaño O, Balolong-Garcia JC, Datukan JTY. Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study. Cancer Rep (Hoboken) 2021;:e1426. [PMID: 34021716 DOI: 10.1002/cnr2.1426] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Yekedüz E, Utkan G, Ürün Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer 2020;141:92-104. [PMID: 33130550 DOI: 10.1016/j.ejca.2020.09.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
86 Switzer B, Haanen J, Lorigan PC, Puzanov I, Turajlic S. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer 2021;9:e002835. [PMID: 34272309 DOI: 10.1136/jitc-2021-002835] [Reference Citation Analysis]
87 Wu JT, Kwon DH, Glover MJ, Henry S, Wood D, Rubin DL, Koshkin VS, Schapira L, Shah SA. Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California. JCO Oncol Pract 2021;17:e377-85. [PMID: 33332170 DOI: 10.1200/OP.20.00790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
88 Martinez-recio S, Perez-wert JP, Martinez-fdez S, Jimenez-bou D, Ruiz-gutierrez I, Peña J, Pertejo A, Espinosa E, Pinto A. COMPARISON OF 2-WEEKLY AND 3-WEEKLY DOSING OF DOCETAXEL IN METASTATIC PROSTATE CANCER. Clinical Genitourinary Cancer 2022. [DOI: 10.1016/j.clgc.2022.02.009] [Reference Citation Analysis]
89 Chen N, Jotwani A, Li A. Care Delivery in Cancer Patients With Asymptomatic COVID-19 Infection in a Tertiary, Safety-Net Hospital in Houston, Texas. Am J Clin Oncol 2021;44:409-12. [PMID: 34107500 DOI: 10.1097/COC.0000000000000837] [Reference Citation Analysis]
90 Chiruvella V, Ullah A, Elhelf I, Patel N, Karim NA. Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion? Front Oncol 2022;12:871132. [DOI: 10.3389/fonc.2022.871132] [Reference Citation Analysis]
91 Reese JB, El-jawahri A, Sorice K, Cruz C, Bober SL, Daly MB, Zimmaro LA, Beach MC, Wittenberg E, Wolff AC, Handorf E, Lepore SJ. Investigating the impact of the COVID-19 pandemic on breast cancer clinicians’ communication about sexual health. Support Care Cancer. [DOI: 10.1007/s00520-022-07003-8] [Reference Citation Analysis]
92 Tashkandi E, Al-Abdulwahab A, Basulaiman B, Alsharm A, Al-Hajeili M, Alshadadi F, Halawani L, Al-Mansour M, Alquzi B, Barnawi S, Alghamdi M, Abdelaziz N, Azher R. Mortality and morbidity of curative and palliative anticancer treatments during the COVID-19 pandemic: A multicenter population-based retrospective study. Mol Clin Oncol 2021;14:82. [PMID: 33758663 DOI: 10.3892/mco.2021.2244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Cheung MC, Franco BB, Meti N, Thawer A, Tahmasebi H, Shankar A, Loblaw A, Wright FC, Fox C, Peek N, Sim V, Singh S. Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process. Curr Oncol 2021;28:5332-45. [PMID: 34940084 DOI: 10.3390/curroncol28060445] [Reference Citation Analysis]
94 Amatu A, Pani A, Patelli G, Gagliardi OM, Loparco M, Piscazzi D, Cassingena A, Tosi F, Ghezzi S, Campisi D, Grifantini R, Abrignani S, Siena S, Scaglione F, Sartore-Bianchi A. Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment. Eur J Cancer 2021;163:16-25. [PMID: 35032813 DOI: 10.1016/j.ejca.2021.12.006] [Reference Citation Analysis]
95 Mair MJ, Berger JM, Berghoff AS, Starzer AM, Ortmayr G, Puhr HC, Steindl A, Perkmann T, Haslacher H, Strassl R, Tobudic S, Lamm WW, Raderer M, Mitterer M, Fuereder T, Fong D, Preusser M. Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations. JAMA Oncol 2021;:1-8. [PMID: 34591965 DOI: 10.1001/jamaoncol.2021.5437] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Favara DM, McAdam K, Cooke A, Bordessa-Kelly A, Budriunaite I, Bossingham S, Houghton S, Doffinger R, Ainsworth N, Corrie PG. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic. Clin Oncol (R Coll Radiol) 2021;33:667-75. [PMID: 33941453 DOI: 10.1016/j.clon.2021.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Singh S, Singh J, Paul D, Jain K. Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence. Clin Lymphoma Myeloma Leuk 2021;21:289-94. [PMID: 33558204 DOI: 10.1016/j.clml.2021.01.004] [Reference Citation Analysis]
98 Tang M, Daniels B, Aslam M, Schaffer A, Pearson SA. Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study. Lancet Reg Health West Pac 2021;:100226. [PMID: 34368796 DOI: 10.1016/j.lanwpc.2021.100226] [Reference Citation Analysis]
99 Liontos M, Kastritis E, Migkou M, Koutsoukos K, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Psaltopoulou T, Zagouri F, Terpos E, Dimopoulos MA. Response of an oncology unit in the midst of the COVID-19 outbreak. J Oncol Pharm Pract 2020;26:1947-52. [PMID: 33092498 DOI: 10.1177/1078155220967973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Lim KHJ, Murali K, Kamposioras K, Punie K, Oing C, O'Connor M, Thorne E, Amaral T, Garrido P, Lambertini M, Devnani B, Westphalen CB, Morgan G, Haanen JBAG, Hardy C, Banerjee S. The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II. ESMO Open 2021;6:100199. [PMID: 34217129 DOI: 10.1016/j.esmoop.2021.100199] [Reference Citation Analysis]